Somatostatin-derived amyloid deposition associated with duodenal neuroendocrine tumour (NET): a report of novel localised amyloidosis associated with NET
Amyloid
.
2022 Mar;29(1):64-65.
doi: 10.1080/13506129.2021.1979513.
Epub 2021 Sep 22.
Authors
Shojiro Ichimata
1
2
,
Nagaaki Katoh
3
,
Ryuta Abe
3
,
Tsuneaki Yoshinaga
3
,
Fuyuki Kametani
4
,
Masahide Yazaki
5
,
Yukiko Kusama
6
,
Kenji Sano
7
,
Takeshi Uehara
2
,
Yoshiki Sekijima
3
Affiliations
1
Department of Legal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
2
Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan.
3
Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan.
4
Department of Dementia and Higher Brain Function, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
5
Institute for Biomedical Sciences, Shinshu University, Matsumoto, Japan.
6
Department of Pathology, Nagano Municipal Hospital, Nagano, Japan.
7
Department of Pathology, Iida Municipal Hospital, Iida, Japan.
PMID:
34549672
DOI:
10.1080/13506129.2021.1979513
No abstract available
Publication types
Letter
MeSH terms
Amyloidosis* / complications
Humans
Intestinal Neoplasms* / complications
Neuroendocrine Tumors* / complications
Neuroendocrine Tumors* / pathology
Pancreatic Neoplasms* / complications
Somatostatin
Substances
Somatostatin